BPK Bespak

TIDMCSRT

RNS Number : 3961E

Consort Medical PLC

03 November 2015

Consort Medical plc

3 November 2015

Appointment of Group General Counsel and Company Secretary

Consort Medical plc announces that John Ilett has joined the Company as Group General Counsel and Company Secretary with immediate effect.

John has over 20 years of experience in the pharmaceutical/life sciences sector and brings a wealth of experience to the position from previous senior legal roles. These include at LGC Group Limited where he was General Counsel and Company Secretary from 2010 to 2015, and senior legal roles at Biomarin Pharmaceutical, Inc., Cephalon, Inc., Oxford Glycosciences plc and British Biotech plc. John also worked in private practice for several years at Stringer Saul (now Faskens). John is a qualified solicitor.

Enquiries:

 
 Consort Medical                             Tel: +44 1442 867 
  Jonathan Glenn - Chief Executive Officer    920 
  Richard Cotton - Chief Financial Officer 
 
   FTI Consulting                              Tel: +44 203 727 
   Ben Atwell/ Simon Conway                    1000 
 

Consort Medical plc is a leading, global, single source drug and delivery device company (CDMO). We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Our businesses

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners.

We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Nottingham, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). To learn more about our company visit our website at www.consortmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

COSFSIFEDFISELF

(END) Dow Jones Newswires

November 03, 2015 07:47 ET (12:47 GMT)

Bespak (LSE:BPK)
Historical Stock Chart
From Apr 2024 to May 2024

Bespak (LSE:BPK)
Historical Stock Chart
From May 2023 to May 2024